Citations

Showing 10 of 108152 citations.

Posterior cortical atrophy phenotypic heterogeneity revealed by decoding 18F-FDG-PET
Townley, Ryan , Botha, Hugo , Graff‐Radford, Jonathan , Whitwell, Jennifer , Boeve, Bradley F. , Fields, Julie A. , Drubach, Daniel A., Savica, Rodolfo , Petersen, Ronald C. , Lowe, Val J. , Jack, Clifford R. , Josephs, Keith A. , Townley, Ryan A , Jack, Clifford R , Josephs, Keith A , Boeve, Brad , Botha, Hugo , Machulda, Mary M. , Senjem, Matthew L. , Knopman, David S. , Jones, David T.

Mayo Clinic

Brain Communications | August 17, 2021 | Volume: 3 | Issue: 4 | Pages: No page available

10.1093/braincomms/fcab182 | PMID 34805993 Get It

Abstract Posterior cortical atrophy is a neurodegenerative syndrome with a heterogeneous clinical presentation due to variable involvement of the left, right, dorsal and ventral parts of the visual system, as well as inconsistent involvement of other cognitive domains and systems. 18F-fluorodeoxyglucose (FDG)-PET is a sensitive marker for regional brain damage or dysfunction, capable of capturing the pattern of neurodegeneration at the single-participant level. We aimed to leverage these inter-individual differences on FDG-PET imaging to better understand the associations of heterogeneity of posterior cortical atrophy. We identified 91 posterior cortical atrophy participants with FDG-PET data and abstracted demographic, neurologic, neuropsychological and Alzheimer’s disease biomarker data. The mean age at reported symptom onset was 59.3 (range: 45–72 years old), with an average disease duration of 4.2 years prior to FDG-PET scan, and a mean education of 15.0 years. Females were more common than males at 1.6:1. After standard preprocessing steps, the FDG-PET scans for the cohort were entered into an unsupervised machine learning algorithm which first creates a high-dimensional space of inter-individual covariance before performing an eigen-decomposition to arrive at a low-dimensional representation. Participant values (‘eigenbrains’ or latent vectors which represent principle axes of inter-individual variation) were then compared to the clinical and biomarker data. Eight eigenbrains explained over 50% of the inter-individual differences in FDG-PET uptake with left (eigenbrain 1) and right (eigenbrain 2) hemispheric lateralization representing 24% of the variance. Furthermore, eigenbrain-loads mapped onto clinical and neuropsychological data (i.e. aphasia, apraxia and global cognition were associated with the left hemispheric eigenbrain 1 and environmental agnosia and apperceptive prosopagnosia were associated with the right hemispheric eigenbrain 2), suggesting that they captured important axes of normal and abnormal brain function. We used NeuroSynth to characterize the eigenbrains through topic-based decoding, which supported the idea that the eigenbrains map onto a diverse set of cognitive functions. These eigenbrains captured important biological and pathophysiologic data (i.e. limbic predominant eigenbrain 4 patterns being associated with older age of onset compared to frontoparietal eigenbrain 7 patterns being associated with younger age of onset), suggesting that approaches that focus on inter-individual differences may be important to better understand the variability observed within a neurodegenerative syndrome like posterior cortical atrophy.
Development, Validation, and Results of a Survey of Personal Electronic Device Use Among 299 Anesthesia Providers From a Single Institution
Paredes, Stephania , Roscher, Christopher, Plevak, Matthew F., Yost, Kathleen J. , Porter, Steven B. , Renew, J. Ross

Mayo Clinic

Anesthesia & Analgesia | August 17, 2021 | Volume: 134 | Issue: 2 | Pages: 269-275

10.1213/ane.0000000000005708 | PMID 34403379 Get It

BACKGROUND: The pattern of perioperative use of personal electronic devices (PEDs) among anesthesia providers in the United States is unknown. METHODS: We developed a 31-question anonymous survey of perioperative PED use that was sent to 813 anesthesiologists, anesthesiology residents, and certified registered nurse anesthetists at 3 sites within one health system. The electronic survey assessed patterns of PED use inside the operating room (OR), outside the OR, and observed in others. Questions were designed to explore the various purposes for PED use, the potential impact of specific hospital policies or awareness of medicolegal risk on PED use, and whether PED was a source of perioperative distraction. RESULTS: The overall survey response rate was 36.8% (n = 299). With regard to often/frequent PED activity inside the OR, 24% reported texting, 5% reported talking on the phone, and 11% reported browsing on the Internet. With regard to often/frequent PED activity outside the OR, 88% reported texting, 26% reported talking on the phone, and 63% reported browsing the Internet. With regard to often/frequent PED activity observed in others, 52% reported others texting, 14% reported others talking on the phone, and 34% reported others browsing the Internet. Two percent of respondents self-reported a distraction compared to 15% who had observed a distraction in others. Eighty percent of respondents recognized PED as a potential distraction for patient safety. CONCLUSIONS: Our data reinforce that PED use is prevalent among anesthesia providers.
Use of plasma late on cardiopulmonary bypass in patients undergoing left ventricular assist device implantation
Nelson, James A. , Soto, Juan C. Diaz , Stulak, John M., Schulte, Phillip J. , Weister, Timothy J. , Mauermann, William J., Diaz Soto, Juan C, Smith, Mark M , Nelson, James A. , Warner, Matthew A. , Smith, Mark M.

Mayo Clinic

Artificial Organs | August 17, 2021 | Volume: 46 | Issue: 3 | Pages: 491-500

10.1111/aor.14052 | PMID 34403155 Get It

AbstractCoagulopathy is common during left ventricular assist device (LVAD) implantation, treatment of which can be challenging given the often‐limited ability for the right ventricle to accommodate volume transfusion after device initiation with 20% to 40% of patients developing right ventricular failure (RVF). Transfusion of plasma late on cardiopulmonary bypass (CPB) combined with ultrafiltration may replace clotting factors while reducing volume administration. We compared outcomes in patients undergoing LVAD implantation receiving plasma on CPB and ultrafiltration with traditional transfusion practices. Co‐primary outcomes needed for blood product transfusion in the first 6 and 24 hours after CPB. Secondary outcomes included metrics of morbidity and mortality. 396 patients were analyzed (59 plasma on CPB). Patients receiving plasma on CPB had a greater volume of blood products transfused (3764 vs. 2741 mL first 6 hours; 6059 vs. 4305 mL first 24 hours) in unadjusted analysis. In adjusted analysis, plasma transfusion on CPB with ultrafiltration had no significant effect on the primary outcomes of blood products given in the first 6 hours (estimated effect size 982 [−428, 2392] mL, P = .17) and 24 hours (estimated effect size 1076 [−904, 3057] mL, P = .29). Patients receiving plasma on CPB were more likely on either vasopressors or inotropes at 24 hours after ICU admission (P = .01), however, indices of coagulopathy and RVF were similar between groups. While prospective studies would be necessary to definitively evaluate the clinical utility of this strategy, no signal for benefit was observed suggesting plasma should not be used for this purpose.
F IO 2 Trajectory as a Pragmatic Intermediate Marker in Acute Hypoxic Respiratory Failure
Chalmers, Sarah , Odeyemi, Yewande , Lal, Amos , Li, Heyi , Frank, Ryan D. , Yadav, Hemang , Chalmers, Sarah J, Odeyemi, Yewande E, Lal, Amos , Chalmers, Sarah , Gajic, Ognjen

Mayo Clinic

Respiratory Care | August 17, 2021 | Volume: 66 | Issue: 10 | Pages: 1521-1530

10.4187/respcare.09053 | PMID 34404689 Get It

BACKGROUND: Several markers of oxygenation are used as prognostic markers in acute hypoxemic respiratory failure. Real-world use is limited by the need for invasive measurements and unreliable availability in the electronic health record. A pragmatic, reliable, and accurate marker of acute hypoxemic respiratory failure is needed to facilitate epidemiologic studies, clinical trials, and shared decision-making with patients. F IO 2 is easily obtained at the bedside and from the electronic health record. The F IO 2 trajectory may be a valuable marker of recovery in patients with acute hypoxemic respiratory failure. METHODS: This was a historical cohort study of adult subjects admitted to an ICU with acute hypoxemic respiratory failure secondary to community-acquired pneumonia and/or ARDS. RESULTS: Our study included 2,670 subjects. F IO 2 and S pO 2 were consistently more available than was P aO 2 in the electronic health record: (F IO 2 vs S pO 2 vs P aO 2 : 100 vs 100 vs 72.8% on day 1, and 100 vs 99 vs 21% on day 5). A worsening F IO 2 trajectory was associated with reduced ventilator-free days. From days 2 to 5, every increase in F IO 2 by 10% from the previous day was associated with fewer ventilator-free days (on day 2: adjusted mean –1.25 [95% CI –1.45 to –1.05] d, P < .001). The S pO 2 /F IO 2 trajectory also provided prognostic information. On days 3 – 5, an increase in S pO 2 /F IO 2 from the previous day was associated with increased ventilator-free days (on day 3: adjusted mean 2.09 (95% CI 1.44–2.74) d; P < .001). S pO 2 /F IO 2 models did not add predictive information compared with models with F IO 2 alone (on day 2: adjusted F IO 2 vs S pO 2 /F IO 2 R2 0.122 vs 0.119; and on day 3: 0.153 vs 0.163). CONCLUSIONS: F IO 2 and S pO 2 /F IO 2 are pragmatic and readily available intermediate prognostic markers in acute hypoxic respiratory failure. The F IO 2 trajectory in the first 5 d of ICU admission provided important prognostic information (ventilator-free days). Although the S pO 2 /F IO 2 trajectory was also associated with ventilator-free days, it did not provide more information than the F IO 2 trajectory alone.
Sex Difference in the Relation Between Marital Status and Dementia Risk in Two Population-Based Cohorts
Aakre, Jeremiah A. , Vassilaki, Maria , Wetterberg, Hanna , Zettergren, Anna , Petersen, Ronald C. , Kern, Silke , Najar, Jenna , Rydén, Lina , Skoog, Ingmar , Jack, Clifford R. , Knopman, David S. , Mielke, Michelle M.

Mayo Clinic

Journal of Alzheimer's Disease | August 17, 2021 | Volume: 83 | Issue: 3 | Pages: 1269-1279

10.3233/jad-210246 | PMID 34420952 Get It

Background: The modifying effect of sex on the relation between marital status and dementia has yet to be determined. Objective: To examine if sex modifies the association between marital status and incident dementia. Methods: Population-based samples from the Mayo Clinic Study of Aging (MCSA, N = 3,471) and the Gothenburg H70 Birth Cohort Study (H70-study, N = 913) were used. A multiplicative interaction term was used to analyze the modifying effect of sex on the relation between marital status (married versus not married) and incident dementia using Cox regression models. Further, risk of dementia by marital status was also evaluated in models separated by sex. Results: In the MCSA, there was an interaction between marital status and sex in relation to dementia (p = 0.015). In contrast, in the H70-study, no significant interaction was observed (p = 0.28). Nevertheless, in both studies, not married men had increased risk of dementia compared to married men in models adjusted for age, education, and number of children (H70-study: 1.99; 1.06–3.76, MCSA: 1.43; 1.08–1.89). Associations remained similar after additional adjustment for depression, BMI, hypertension, dyslipidemia, and diabetes mellitus (H70-study: 2.00; 1.05–3.82, MCSA: 1.32; 0.99–1.76). Further, no significant association was observed between marital status and dementia in women (H70-study: 1.24; 0.82–1.89, MCSA: 0.82; 0.64–1.04). Conclusion: Sex had a modifying effect on the association between marital status and incident dementia. In analyses separated by sex, not married men had an increased risk of dementia compared to married men, while no significant association was observed between marital status and risk of dementia in women.
Genetic analyses of SERPINA5 in Alzheimer’s disease
Lincoln, Sarah, Baker, Matt , Tamvaka, Nikoleta, Cabrera-Rodriguez, Janisse, Helminger, Jacqueline, Hinkle, Kelly M., Duara, Ranjan , Graff‐Radford, Neill R. , Ertekin‐Taner, Nilüfer , Rademakers, Rosa , Matchett, Billie J. , Labuzan, Sydney A. , Duara, Ranjan , Ross, Owen A. , Dickson, Dennis W. , Murray, Melissa E.

Mayo Clinic

No container title available | August 17, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-769744/v1 Get It

Abstract Alzheimer’s disease (AD) is a progressive neurodegenerative disease that is the most common cause of dementia. Our previous studies have shown that increased expression of the SERPINA5 gene is associated with hippocampal vulnerability in AD, and that the SERPINA5 protein binds to tau and co-localizes within neurofibrillary tangles. To determine if genetic variants in the SERPINA5 gene may be contributing to this phenotype, we sequenced 103 autopsy-confirmed young-onset AD cases with a positive family history of cognitive decline. We observed one individual with a rare missense variant (rs140138746) in the SERPINA5 gene, resulting in an amino acid change (p.E228Q). We screened a further 1170 neuropathologically diagnosed AD cases and identified an additional 5 carriers of this variant, resulting in an allelic frequency of 0.002141 within our AD validation cohort, which was comparable to online genomic databases. Although not significant, SERPINA5 p.E228Q variant carriers were found to be younger at age of onset and age of death than non-carriers. SERPINA5 p.E228Q variant carriers had a longer disease duration than non-carriers, which approached significance. To further elucidate possible neuropathologic contributions of the SERPINA5 p.E228Q variant, we carried out descriptive neuropathologic burden analysis on a variant carrier that was matched to a non-carrier for age, sex, disease duration, Braak tangle stage, TDP-43 positive status, and who possessed an APOE ε4 risk allele. Interestingly, SERPINA5 burden was lower in the SERPINA5 p.E228Q carrier than the non-carrier in 9 corticolimbic brain regions studied, which exaggerated the tau:SERPINA5 immunohistochemical ratio. The SERPINA5 p.E228Q carrier was observed to have more severe neuronal loss in several brain regions compared to the non-carrier. Together, we cautiously interpret these findings to suggest that the SERPINA5 p.E228Q variant may stall tangle maturity and slow AD disease progression, thus prolonging disease duration in these individuals.
Individualized management of cytomegalovirus in solid organ transplant recipients
Saeed, Huma, Thoendel, Matthew , Razonable, Raymund R.

Mayo Clinic

Expert Review of Precision Medicine and Drug Development | August 17, 2021 | Volume: 6 | Issue: 5 | Pages: 333-344

10.1080/23808993.2021.1964951 Get It

Bioethics Theory-Building for Public Health
Meagher, Karen M. , Meagher, Karen M

Mayo Clinic

The American Journal of Bioethics | August 17, 2021 | Volume: 21 | Issue: 9 | Pages: 53-56

10.1080/15265161.2021.1952344 | PMID 34399663 Get It

Teaching about Health Disparities: Pedagogy, Curriculum, and Learning Theory
Laughlin-Tommaso, Shannon K., Renner, Amy Seegmiller , Seegmiller Renner, Amy, Clarke, Michelle J.

Mayo Clinic

The American Journal of Bioethics | August 17, 2021 | Volume: 21 | Issue: 9 | Pages: 18-20

10.1080/15265161.2021.1952340 | PMID 34399675 Get It

KLF10 integrates circadian timing and sugar signaling to coordinate hepatic metabolism
Ruberto, Anthony A. , Gréchez‐Cassiau, Aline, Guérin, Sophie , Martin, Luc , Revel, Johana S., Mehiri, Mohamed, Subramaniam, Malayannan , Delaunay, Franck , Teboul, Michèle

Mayo Clinic

eLife | August 17, 2021 | Volume: 10 | Issue: No issue available | Pages: No page available

10.7554/elife.65574 | PMID 34402428 Get It

The mammalian circadian timing system and metabolism are highly interconnected, and disruption of this coupling is associated with negative health outcomes. Krüppel-like factors (KLFs) are transcription factors that govern metabolic homeostasis in various organs. Many KLFs show a circadian expression in the liver. Here, we show that the loss of the clock-controlled KLF10 in hepatocytes results in extensive reprogramming of the mouse liver circadian transcriptome, which in turn alters the temporal coordination of pathways associated with energy metabolism. We also show that glucose and fructose induce Klf10, which helps mitigate glucose intolerance and hepatic steatosis in mice challenged with a sugar beverage. Functional genomics further reveal that KLF10 target genes are primarily involved in central carbon metabolism. Together, these findings show that in the liver KLF10 integrates circadian timing and sugar metabolism-related signaling, and serves as a transcriptional brake that protects against the deleterious effects of increased sugar consumption.